Nippon Shinyaku Co., Ltd.

Quick facts

Marketed products

• Cytarabine · Oncology
  Cytarabine inhibits DNA polymerase and incorporates into DNA/RNA, killing cells in S-phase.

Phase 1 pipeline

• [14C] NS-580

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nippon Shinyaku Co., Ltd. portfolio CI brief
• Nippon Shinyaku Co., Ltd. pipeline updates RSS